Log in to save to my catalogue

Lymphangiogenic therapy prevents cardiac dysfunction by ameliorating inflammation and hypertension

Lymphangiogenic therapy prevents cardiac dysfunction by ameliorating inflammation and hypertension

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cffe82a9df6a402a999f6d3b68cbed94

Lymphangiogenic therapy prevents cardiac dysfunction by ameliorating inflammation and hypertension

About this item

Full title

Lymphangiogenic therapy prevents cardiac dysfunction by ameliorating inflammation and hypertension

Publisher

England: eLife Science Publications, Ltd

Journal title

eLife, 2020-11, Vol.9

Language

English

Formats

Publication information

Publisher

England: eLife Science Publications, Ltd

More information

Scope and Contents

Contents

The lymphatic vasculature is involved in the pathogenesis of acute cardiac injuries, but little is known about its role in chronic cardiac dysfunction. Here, we demonstrate that angiotensin II infusion induced cardiac inflammation and fibrosis at 1 week and caused cardiac dysfunction and impaired lymphatic transport at 6 weeks in mice, while co-adm...

Alternative Titles

Full title

Lymphangiogenic therapy prevents cardiac dysfunction by ameliorating inflammation and hypertension

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_cffe82a9df6a402a999f6d3b68cbed94

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cffe82a9df6a402a999f6d3b68cbed94

Other Identifiers

ISSN

2050-084X

E-ISSN

2050-084X

DOI

10.7554/eLife.58376

How to access this item